Cancer Research Annual Meeting 2010  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nosaka, K.
Right arrow Articles by Matsuoka, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nosaka, K.
Right arrow Articles by Matsuoka, M.
[Cancer Research 60, 1043-1048, February 15, 2000]
© 2000 American Association for Cancer Research


Molecular Biology and Genetics

Increasing Methylation of the CDKN2A Gene Is Associated with the Progression of Adult T-Cell Leukemia1

Kisato Nosaka, Michiyuki Maeda, Sadahiro Tamiya, Tatsunori Sakai, Hiroaki Mitsuya and Masao Matsuoka2,3

Department of Internal Medicine II, Kumamoto University School of Medicine, Kumamoto 860-8556 [K. N., S. T., T. S., H. M., M. Mat.], Institute for Frontier Medical Sciences, Kyoto University, Kyoto 606-8507 [M. Mae.], Japan

In this study, we examined the methylation status of the CDKN2A gene in patients with different forms of adult T-cell leukemia (ATL) using Southern blot analysis, methylation-specific PCR (MSPCR), and nucleotide sequencing. We found that the CDKN2A gene was more frequently methylated in fresh tumor cells isolated from patients with acute ATL (47%) or lymphoma-type ATL (73%) than in those with less malignant chronic (17%) and smoldering (17%) ATL. In addition, deletions of the CDKN2A gene were found in 24% of acute ATL patients; thus, abnormalities of the CDKN2A gene totaled 71% in acute ATL patients. In contrast, no CDKN2A gene methylation was found in asymptomatic carriers or uninfected individuals. Methylation of the p15 gene was not found in any samples from 36 ATL patients. Direct sequencing of the CDKN2A gene after sodium bisulfite treatment of genomic DNA revealed that the methylation of CpG sites had occurred in 24 of 32 ATL cases (75%) including chronic and smoldering ATL, even when MSPCR and the Southern blot had failed to detect CDKN2A gene methylation. Among fresh ATL samples with methylation, methylation was detected in the promoter region and exon in 17 of 24 cases, and methylation in the exon without promoter region was detected in 7 of 24 cases. In one case, the pattern of methylation proved to be different between peripheral blood cells and lymph node cells, suggesting the presence of multiple subclones with regard to methylation patterns, despite the same HTLV-I integration site. Quantitative PCR showed a marked decrease in CDKN2A mRNA expression in the cells with a methylated CDKN2A gene, especially if the promoter region was methylated. These findings suggest that CpG methylation decreases CDKN2A expression and represents a critical factor in the disease progression of ATL.




This article has been cited by other articles:


Home page
BloodHome page
J.-M. Mesnard, B. Barbeau, and C. Devaux
HBZ, a new important player in the mystery of adult T-cell leukemia
Blood, December 15, 2006; 108(13): 3979 - 3982.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Datta, M. Bellon, U. Sinha-Datta, A. Bazarbachi, Y. Lepelletier, D. Canioni, T. A. Waldmann, O. Hermine, and C. Nicot
Persistent inhibition of telomerase reprograms adult T-cell leukemia to p53-dependent senescence
Blood, August 1, 2006; 108(3): 1021 - 1029.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Fan, E.-i. Kodama, Y. Koh, M. Nakao, and M. Matsuoka
Halogenated Thymidine Analogues Restore the Expression of Silenced Genes without Demethylation
Cancer Res., August 1, 2005; 65(15): 6927 - 6933.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. Sasaki, I. Nishikata, T. Shiraga, E. Akamatsu, T. Fukami, T. Hidaka, Y. Kubuki, A. Okayama, K. Hamada, H. Okabe, et al.
Overexpression of a cell adhesion molecule, TSLC1, as a possible molecular marker for acute-type adult T-cell leukemia
Blood, February 1, 2005; 105(3): 1204 - 1213.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J.-i. Yasunaga, Y. Taniguchi, K. Nosaka, M. Yoshida, Y. Satou, T. Sakai, H. Mitsuya, and M. Matsuoka
Identification of Aberrantly Methylated Genes in Association with Adult T-Cell Leukemia
Cancer Res., September 1, 2004; 64(17): 6002 - 6009.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Yoshida, K. Nosaka, J.-i. Yasunaga, I. Nishikata, K. Morishita, and M. Matsuoka
Aberrant expression of the MEL1S gene identified in association with hypomethylation in adult T-cell leukemia cells
Blood, April 1, 2004; 103(7): 2753 - 2760.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Nishinaka, A. Nishiyama, H. Masutani, S.-i. Oka, K. Md. Ahsan, Y. Nakayama, Y. Ishii, H. Nakamura, M. Maeda, and J. Yodoi
Loss of Thioredoxin-Binding Protein-2/Vitamin D3 Up-Regulated Protein 1 in Human T-Cell Leukemia Virus Type I-Dependent T-Cell Transformation: Implications for Adult T-Cell Leukemia Leukemogenesis
Cancer Res., February 15, 2004; 64(4): 1287 - 1292.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. S. Yan, H. Shi, F. Rahmatpanah, T. H-C. Hsiau, A. H-A. Hsiau, Y.-W. Leu, J. C. Liu, and T. H.-M. Huang
Differential Distribution of DNA Methylation within the RASSF1A CpG Island in Breast Cancer
Cancer Res., October 1, 2003; 63(19): 6178 - 6186.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
P. A. Yates, R. Burman, J. Simpson, O. N. Ponomoreva, M. J. Thayer, and M. S. Turker
Silencing of Mouse Aprt Is a Gradual Process in Differentiated Cells
Mol. Cell. Biol., July 1, 2003; 23(13): 4461 - 4470.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
G. Garcia-Manero, C. Bueso-Ramos, J. Daniel, J. Williamson, H. M. Kantarjian, and J.-P. J. Issa
DNA Methylation Patterns at Relapse in Adult Acute Lymphocytic Leukemia
Clin. Cancer Res., June 1, 2002; 8(6): 1897 - 1903.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Nosaka, T. Miyamoto, T. Sakai, H. Mitsuya, T. Suda, and M. Matsuoka
Mechanism of hypercalcemia in adult T-cell leukemia: overexpression of receptor activator of nuclear factor kappa B ligand on adult T-cell leukemia cells
Blood, January 15, 2002; 99(2): 634 - 640.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
C.S. Chim, R. Liang, C.Y.Y. Tam, and Y.L. Kwong
Methylation of p15 and p16 Genes in Acute Promyelocytic Leukemia: Potential Diagnostic and Prognostic Significance
J. Clin. Oncol., April 1, 2001; 19(7): 2033 - 2040.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.